Popliteal lymphadenectomy for treating metastatic melanoma
case report
Keywords:
Melanoma, Lymphatic metastasis, Lymphadenectomy, Skin neoplasms, Lower extremityAbstract
CONTEXT: Regional lymph node involvement in patients with malignant melanomas has been associated with poor prognosis. In-transit metastases also lead to poor long-term survival. Whereas for nodal disease only regional lymphadenectomy offers adequate locoregional control, for in-transit metastasis both local excision and isolated limb perfusion with chemotherapy plus tumor necrosis factor-alpha can be used for disease control. In cases of tumors located in the distal region of the legs, the lymphatic dissemination most commonly observed is to the inguinal chain. Consequently, therapeutic inguinal lymphadenectomy or even selective lymphadenectomy (sentinel lymph node biopsy) have been recommended. On the other hand, involvement of the popliteal chain is very rare. When this occurs, popliteal lymphadenectomy should be indicated. Local excision may be the logical approach for a few small in-transit metastases because of the low morbidity in this procedure, when compared with isolated limb perfusion. CASE REPORT: A case of melanoma of the heel with popliteal chain involvement and in-transit metastases is presented. This was treated by means of regional lymphadenectomy plus in-transit metastases excision, with a good postoperative course.
Downloads
References
McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137(5):543-7; discussion 547-9.
Pawlik TM, Gershenwald JE. Melanoma. In: Feig BW, Berger DH, Fuhrman GM, editors. The M.D. Anderson surgical on- cology handbook. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 60-111.
Georgeu G, El-Muttardi N, Mercer D. Malignant melanoma metastasis to the sentinel node in the popliteal fossa. Br J Plast Surg. 2002;55(5):443-5.
Marone U, Caracò C, Chiofalo MG, Botti G, Mozzillo N. Resection in the popliteal fossa for metastatic melanoma. World J Surg Oncol. 2007;5:8.
Karakousis CP. The technique of popliteal lymph node dissec- tion. Surg Gynecol Obstet. 1980;151(3):420-3.
Hatta N, Morita R, Yamada M, Takehara K, Ichiyanagi K, Yokoyama K. Implications of popliteal lymph node detected by sentinel lymph node biopsy. Dermatol Surg. 2005;31(3): 327-30.
Uhara H, Saida T, Watanabe T, Takizawa Y. Lymphangitis of the foot demonstrating lymphatic drainage pathways from the sole. J Am Acad Dermatol. 2002;47(4):502-4.
Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol. 2000;26(2):172-6.
Menes TS, Schachter J, Steinmetz AP, Hardoff R, Gutman H. Lymphatic drainage to the popliteal basin in distal lower extrem- ity malignant melanoma. Arch Surg. 2004;139(9):1002-6.
Grünhagen DJ, de Wilt JH, van Geel AN, Eggermont AM. Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha. Eur J Surg Oncol. 2006;32(4):371-80.
Grünhagen DJ, Brunstein F, Graveland WJ, van Geel AN, de Wilt JH, Eggermont AM. One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Ann Surg. 2004;240(6):939-47; discussion 947-8.
Sholar A, Martin RC 2nd, McMasters KM. Popliteal lymph node dissection. Ann Surg Oncol. 2005;12(2):189-93.
Creech O Jr, Krementz ET, Ryan RF, Winblad JN. Chemo- therapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958;148(4):616-32.
Benckhuijsen C, Kroon BB, van Geel AN, Wieberdink J. Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol. 1988;14(2):157-63.
Thompson JF, Gianoutsos MP. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J Surg. 1992;16(2):227-33.
Eggermont AM. Treatment of melanoma in-transit metastases confined to the limb. Cancer Surv. 1996;26:335-49.
Klaase JM, Kroon BB, Benckhuijsen C, van Geel AN, Albus- Lutter CE, Wieberdink J. Results of regional isolation perfu- sion with cytostatics in patients with soft tissue tumors of the extremities. Cancer. 1989;64(3):616-21.
Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in com- bination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992;10(1):52-60.
Lejeune F, Liénard D, Eggermont A, et al. Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma. J Cell Biochem. 1994;56(1):52-61.
